Clinical Trial Update: Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 dose-regimen study of AZD1656 in Japanese patients with Type 2 Diabetes Mellitus, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2012-08-27